Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05669131
Other study ID # MIT&ForceSteadiness
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 2022
Est. completion date August 2023

Study information

Verified date December 2022
Source University of British Columbia
Contact Jennifer Jakobi, PhD
Phone 250-807-9884
Email jennifer.jakobi@ubc.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is learn about motor imagery training (i.e. imagining a task) with healthy older adults. The main question this clinical trial aims to answer is: • Will imagining a task improve control of force during an elbow flexion muscle contraction in healthy older adults? Participants will: - Complete questionaries about general activity levels and ability to imagine tasks - Perform either motor imagery training or watch a documentary - Perform maximal and submaximal elbow flexion contractions Researchers will compare the motor imagery training with the control group to see if control of force is improved in the motor imagery training group.


Description:

Motor imagery training could be beneficial in rehabilitative settings when participants are not physically capable of preforming a motor task or in injury prevention scenarios such as when multiple repetitions of a motor task should not be performed. If the effects of motor imagery training are favourable then they could have meaningful influence on the performance of steady movements in older adults who experience declines in force steadiness with age. Therefore, the first aim of this study will be to determine if one session of motor imagery training will influence corticospinal excitability in older adults and improve force steadiness during isometric elbow flexion contractions with the observed benefit being greater in females. The second aim of this study will be to determine if there is an associated change in oscillations in common synaptic input to motor neurons with a change in force steadiness.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date August 2023
Est. primary completion date August 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years to 90 Years
Eligibility Inclusion Criteria: Healthy older adults aged 65 to 90 years old Exclusion Criteria: 1. have had an injury or orthopaedic surgery to the arm or shoulder in the prior 6 months 2. are involved in high levels of upper-body strength training 3. have history of training in fine motor tasks (i.e., musicians) 4. have a history of MIT 5. have systemic diseases and/or nerve damage affecting neuromuscular function 6. have severe cognitive impairment 7. are unable to read or speak English fluently 8. are left hand dominant

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Motor imagery training
Participants imagine themselves through their own eyes performing submaximal elbow flexion contractions.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of British Columbia

Outcome

Type Measure Description Time frame Safety issue
Primary Force steadiness Measured as the the coefficient in variation of force Within one session: Change from baseline (immediately before session) to 20 minutes after the session
Primary Corticospinal excitability Measured as the peak-to-peak amplitude of a motor evoked potential Within one session: Change from baseline (immediately before session) to 20 minutes after the session
Primary Common synaptic input Estimated from motor unit discharge times. Within one session: Change from baseline (immediately before session) to 20 minutes after the session
Secondary Maximal elbow flexion force The total amount of force produced during a maximal contraction Within one session: Change from baseline (immediately before session) to 20 minutes after the session
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1